Antidepressant trial aims to ease IBD suffering
NCT ID NCT07431606
Summary
This study is testing whether the antidepressant medication duloxetine can help reduce psychological distress and improve daily functioning in adults with inflammatory bowel disease (IBD). Thirty-two participants with elevated anxiety, depression, or IBD-related disability will take duloxetine daily for six weeks while tracking their symptoms. The goal is to see if this medication is tolerable and shows early signs of helping with the gut-brain connection in IBD.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.